Inspira Global, backed by Ajanta Pharma promoters, is securing ₹1,800 crore in private credit to acquire a controlling stake in Burger King...

Delhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'P...

Assam has officially entered the premium Matcha tea market, with the state's first commercially produced batch fetching an impressive Rs 30...

Corning broke ground for a new optical connectivity manufacturing facility in Pune in February this year. The plant is being built alongsid...

As Japanese Prime Minister Sanae Takaichi visits India, industry sees the biggest opportunity not in tariff concessions but in supplier eco...

In just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...

Given the state of the market these days, it would be wise to be selective. Not only in terms of stocks, but also in terms of sectors. For ...

Now, there is nothing wrong with being bullish, because it has always paid to be bullish. Yes, one might argue that it has not paid in the ...

Adar Poonawalla's family office has injected Rs 700 crore into Inox Clean Energy, This significant investment bolsters Inox Clean's integra...

Cigna's Evernorth has unveiled Pharmacy Forward, an AI-driven specialty pharmacy program backed by a $100 million investment. This initiati...

India’s healthcare market may grow steadily, but hospital chains can grow faster as formalisation continues. Healthcare is all about market...

The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...

Indian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...

Indian reinsurer GIC Re is strategically shifting its overseas business focus. Amidst escalating climate-related losses globally, the compa...

India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...

Indian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...

India's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...